06/29
Headlines

Healthcare Losers: CytRx (NASDAQ:CYTR), Trivascular Technologies (NASDAQ:TRIV), Neuralstem (NYSEMKT:CUR), Ventrus Biosciences Inc (NASDAQ:VTUS)

Kristen Barton03 mins

The company on May 28 announced updated results from its ongoing multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas (STS). CytRx Corporation (NASDAQ:CYTR) stock performance was -5.41% in last session and…

Read More

Morning Alert : eLong (NASDAQ:LONG), GSI Technology (NASDAQ:GSIT), TAL Education Group (NYSE:XRS), Atlas Financial Holdings, Inc. (NASDAQ:AFH), Curis, Inc. (NASDAQ:CRIS)

Jason Knox03 mins

eLong, Inc. (NASDAQ:LONG), a leading mobile and online travel service provider in China, on 07 Aug 2014 reported unaudited financial results for the second quarter ended June 30, 2014. Hotel room nights stayed in the second quarter increased 44%  to 8.3 million room nights compared to 5.8 million in the prior year period. Hotel commission…

Read More

Active Watch List – Petroleo Brasileiro Petrobras (NYSE:PBR) , Broadcom Corporation (NASDAQ:BRCM) , The Dow Chemical (NYSE:DOW) , Yingli Green Energy (NYSE:YGE)

Kevin Long02 mins

Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Brazil’s state-controlled oil producer, rose to the highest in more than seven months after Goldman Sachs Group Inc. recommended the stock as its top energy pick in Latin America. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) stock performance was -0.25% in last session and finished the day at $15.84. Traded…

Read More

Biotech New Highs: Five Prime Therapeutics Inc (NASDAQ:FPRX), Albany Molecular Research (NASDAQ:AMRI), Vanda Pharmaceuticals (NASDAQ:VNDA), Chimerix Inc (NASDAQ:CMRX)

Kevin Long02 mins

Five Prime therapeutics Inc. (NASDAQ:FPRX) has announced it has entered into a collaboration agreement with Bristol Myers Squibb Co (NYSE:BMY) for the discovery and development of immune-oncology therapies. Five Prime Therapeutics Inc (NASDAQ:FPRX) stock performance was 22.61% in last session and finished the day at $22.99. Traded volume was 1,287,393 million shares in the last…

Read More

Cumulus Media Posts Solid Quarterly Results

John Meady02 mins

Cumulus Media (NASDAQ:CMLS) reported net revenues of $328M for the fourth quarter. 4Q revenue was positively impacted by healthy advertising trends across auto, healthcare and financial services, slightly offset by weakness across retail, tracking weaker holiday sales. EBITDA was $96M (+6% yoy), mostly driven by investments that took place earlier in the year, improving margins…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓